查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439240

血管接取装置 - 全球市场考量、竞争格局、市场预测 (2030)

Vascular Access Device - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球血管通路器械市场规模预计2023年将达到45.9亿美元，到2030年将达到67.5亿美元，2024-2030年预测期间复合年增长率为6.64%。对血管通路装置的需求主要是由于需要使用这些装置的慢性疾病（例如癌症、肾衰竭和心臟病）的日益流行所推动的。其他因素，例如化疗使用的增加、生活方式相关疾病以及儿科患者发病率上升也可能支持市场成长。

血管接取装置市场动态

全球慢性病和传染病的流行预计将加速血管通路器械市场的成长。例如，根据Global Cancer Observatory data（2020），2020年全球报告了约573,000例膀胱癌病例。根据同一数据，到 2040 年，这一数字预计将达到 913,000 人。

根据上述数据，2020年全球新诊断肾癌及肾盂癌43.1万例，预计2040年将增加至60.6万例。

根据 Globocan (2020) 的数据，2020 年全球新增前列腺癌患者 141 万人。根据相同的数据，预计到 2040 年将有约 224 万新发前列腺癌病例。

根据International Society of Nephrology发布的最新数据，到2022年，全球将有8.5亿人患有某种形式的肾臟疾病。此外，全世界有 530 万至 1,050 万人需要透析或移植。

然而，与各种血管通路装置相关的併发症和高成本可能会限制整个血管装置市场的成长。

血管接入设备市场细分分析

在血管通路器械市场的器械类型部分，週边放置中心静脉导管（PICC）类别预计将占据最大份额。这是由于 PICC 的相关优势。

PICC 通常插入患有多种疾病（包括癌症和感染）的患者手臂静脉中，用于给药和液体营养。

PICC 允许长期输液和抽血。这使得医生能够进入靠近心臟的大中央静脉以进行有效的药物管理。

PICC 疼痛较小，并且可以避免频繁的针刺。它还可以降低刺激手臂小静脉的风险。

PICC的另一个优点是它具有多个流明。由多个来源供给的管子和盖子构成了管腔。因此，患者可以同时接受多种药物治疗。例如，您可以同时接受静脉输液和化疗。

因此，考虑到与週边插入中心静脉导管（PICC）相关的优势，该产品类别预计将最终产生可观的收入份额，并为预测期内整体血管通路器械市场的成长做出贡献。

北美预计将主导整个血管通路器械市场

预计在预测期内，北美将主导整个血管通路器械市场。这一优点是由于对血管通路装置先进技术的需求增加、慢性病和传染病患者的治疗需求增加以及其他地区产品开发活动的增加所致。

根据American Cancer Society引用的统计数据，2023年美国将报告约82,290例膀胱癌新病例（约62,420名男性和19,870名女性）。

本报告提供了全球血管通路器械市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第1章 血管通路设备市场报告简介

第2章 血管接取装置市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第3章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章 血管接入器械市场关键因素分析

  • 血管接入设备市场驱动因素
    • 慢性病流行
    • 增加化疗
    • 儿科患者生活方式相关疾病的发生率增加
  • 血管通路器械市场的限制与挑战
    • 这些设备放置不当
    • 这些设备的成本很高
  • 血管接取装置的市场机会
    • 人们对肾臟病患者适当补水的兴趣日益浓厚
    • 提高涂有生物活性材料的设备的可用性

第5章 血管通路装置的波特五力分析

第6章 血管通路器械市场布局

  • 按设备类型
    • 中心静脉存取装置
    • 週边静脉接入装置
  • 按插入路径
    • 静脉
    • 皮下
  • 按最终用户
    • 医院
    • 门诊手术中心
    • 其他
  • 按地区
    • 北美血管接取装置市场（2021-2030）
    • 欧洲血管接取装置市场（2021-2030）
    • 亚太地区血管接入器械市场（2021-2030）
    • 其他地区血管接入器械市场（2021-2030）

第7章 血管通路器械公司及产品简介

  • Cook Medical Inc.
  • Becton, Dickinson, and Company
  • Teleflex Incorporated
  • Medtronic PLC
  • B Braun Melsungen AG
  • Nipro Medical Corporation
  • Smiths Group PLC
  • C. R. Bard, Inc.
  • Edwards Lifesciences Corporation
  • AngioDynamics
  • Terumo Medical Corporation
  • Amecath Medical Technologies
  • Prodimed
  • B Braun Melsungen AG
  • Zoll Medical Corporation

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第11章 关于 DelveInsight

第12章 免责声明与联络我们

Product Code: DIMDCL0026

Vascular Access Device Market By Device Type (Central Vascular Access Device [Peripherally Inserted Central Catheters (PICC), Non-Tunneled Catheters, and Others], and Peripheral Vascular Access Device [Peripheral Catheter, Midline Catheter (Short) Devices, and Others]), Route Of Insertion (Intravenous and Subcutaneous), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of infectious diseases and rising technological advancements in the product portfolio

The global vascular access device market was valued at USD 4.59 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 6.75 billion by 2030. The demand for vascular access device is primarily motivated by the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that requires the use of these devices. Some other factors like the rise in the number of chemotherapies, lifestyle diseases, and their rising occurrence in pediatric patients may drive the growth of the market.

Vascular Access Device Market Dynamics:

The increasing prevalence of chronic and infectious diseases globally is going to accelerate the growth of the vascular access device market. For instance, according to Global Cancer Observatory data 2020, globally about 573 thousand cases of bladder cancer were reported in 2020. As per the same source, it has been estimated that by 2040, the number is likely to reach up to 913 thousand.

As per the above-mentioned source, worldwide around 431 thousand new cancer cases of kidney and renal pelvis were diagnosed in 2020 and the cases are expected to increase to 606 thousand by 2040.

The Globocan 2020 says that, worldwide 1.41 million new cases of prostate cancer were registered in 2020. As per the same source, around 2.24 million new cases of prostate cancer are going to be recorded in 2040.

The latest data published by the International Society of Nephrology stated that, worldwide, 850 million people were living with some form of kidney disease in 2022. The source further mentioned that between 5.3 and 10.5 million people needed dialysis or transplantation globally.

However, complications and high costs associated with different vascular access devices may restrict the growth of the overall vascular devices market.

Vascular Access Device Market Segment Analysis:

Vascular Access Device by Device Type (Central Vascular Access Device [Peripherally Inserted Central Catheter (PICC), Non-Tunneled Catheters, and Others], and Peripheral Vascular Access Device [Peripheral Catheter, Midline Catheter (short) Devices, and Others]), Route of Insertion (Intravenous and Subcutaneous), End-User (Hospitals, Ambulatory Surgical Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment of the vascular access device market, the peripherally inserted central catheters (PICC) category under the central vascular access device is expected to hold the largest share. This is owing to the advantages that are associated with PICC.

PICCS are generally used to give medications or liquid nutrition upon insertion through a vein in the arm of patients suffering from various diseases including cancer, infectious diseases, and others.

PICCs allow for long-term access to inject fluids or draw blood. These allow doctors to access the large central veins near the heart for effective administration of medications.

PICCs are associated with less pain and help avoid frequent needle sticks. They also reduce the risk of irritation to the smaller veins present in the arms.

The fact that PICCs can have several lumens is another advantage. The tubing and caps that feed from multiple sources make up a lumen. As a result, a patient may receive multiple medications at once. For instance, they might have fluids and chemotherapy at the same time.

Therefore, considering the advantages associated with peripherally inserted central catheters (PICCs), this product category is expected to generate significant revenue share eventually contributing to the overall growth of the vascular access device market in the forecast period.

North America is expected to dominate the overall Vascular Access Device Market:

North America is expected to dominate the overall vascular access device market during the forecast period. This domination is due to the growing demand for advanced technologies in vascular access devices, the rising need to treat patients suffering from chronic and infectious diseases, and increasing product development activities in the region among others.

The statistics cited by the American Cancer Society, in 2023, stated that about 82,290 new cases of bladder cancer (about 62,420 in men and 19,870 in women will be reported in the US.

According to the Centre for Disease Control and Prevention (CDC) 2020, Cystic fibrosis (CF), a genetic disorder that causes problems with breathing and digestion affects about 35,000 people in the United States, every year on average.

In addition, people suffering from cystic fibrosis need intravenous (IV) antibiotic treatments for more than just a few days, such as during an exacerbation, which could potentially raise the demand for vascular access devices such as PICCs and others.

Also, a rise in hospital enrolment due to a surge in infectious diseases that require the administration of medications in the veins will contribute to the vascular access devices market growth.

For instance, according to CDC 2022, it was estimated that around 1,189,700 people aged 13 and above had HIV in the US in 2019.

Moreover, continuous regulatory approvals in the region are likely to boost the demand for vascular access devices in the coming years. For example, in March 2020, the Biowy PICC-S kit received 510(k) clearance from the US FDA.

Therefore, along with the presence of a large patient pool in the country, the increasing focus of key manufacturers on launching new products in the market is expected to bolster the growth of the vascular access device market in the United States during the forecast period.

Vascular Access Device Market Key Players:

Some of the key market players operating in the vascular access device market include Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others.

Recent Developmental Activities in the Vascular Access Device Market:

In August 2021, PuraCath Medical(TM), a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced that it has received 510(k) clearance for its FireFly(TM) Needleless Connector from the US Food and Drug Administration (FDA). The Firefly(TM) Needleless Connector is a sterile single-patient-use connector for needleless access to the IV line and IV catheter during IV therapy and can be used for direct injection, intermittent infusion, continuous infusion, or aspiration. This regulatory determination by the FDA gives PuraCath clearance to market the FireFly(TM) needleless connector in the US.

In July 2021, Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced it has completed enrolment in its first-in-human study evaluating the company's Amplifi(TM) Vein Dilation System. The Amplifi System is designed to stimulate arm vein enlargement in hemodialysis patients using rapid, non-pulsatile venous blood flow. A novel vein dilation system aims to improve vascular access for hemodialysis patients.

Key Takeaways from the Vascular Access Device Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies are dominating the global vascular access device market.

Various opportunities are available for the other competitor in the vascular access devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vascular access devices market growth in the coming future?

Target audience who can be benefited from this Vascular Access Device Market Key Report Study

Vascular access devices providers

Research organizations and consulting companies

Vascular Access Devices related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in vascular access devices

Various end-users want to know more about the vascular access devices market and the latest technological developments in the vascular access devices market

Frequently Asked Questions for Vascular Access Device Market:

What are Vascular Access Device?

Vascular access device are types of equipment that are inserted inside the body through a vein to enable the administration of fluids, blood products, medication, and other therapies to the bloodstream. These devices allow repeated and long-term access to the bloodstream for frequent or regular administration of drugs, like intravenous (IV) antibiotics. The vascular access tubes are made of silicone, latex, and other substances.

What is the market for global vascular access device?

The global vascular access devices market was valued at USD 4.59 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 6.75 billion by 2030.

What are the drivers for global vascular access device?

The major drivers driving the demand for vascular access devices are the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that requires the use of these devices. Some other factors like a rise in the number of chemotherapies, lifestyle diseases, and their rising occurrence in pediatric patients, technological advancements in product portfolio coupled with the rising number of product launches and approvals are going to assist in the growth of the vascular access devices market.

What are the key players operating in global vascular access devices?

Some of the key market players operating in the vascular access devices market include Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others.

What regions have the highest share in the vascular access devices market?

North America is expected to dominate the overall vascular access devices market during the forecast period, 2024 to 2030. This domination is due to the increasing number of patients with chronic and infectious diseases in the region, the presence of key players, the surge in product development activities, proper reimbursement, and others.

Table of Contents

1. Vascular Access Devices Market Report Introduction

2. Vascular Access Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vascular Access Devices Market Key factors analysis

  • 4.1. Vascular Access Devices Market Drivers
    • 4.1.1. Growing prevalence of chronic diseases
    • 4.1.2. Rise in the number of chemotherapies
    • 4.1.3. Rising occurrence of lifestyle diseases in pediatric patients
  • 4.2. Vascular Access Devices Market Restraints and Challenges
    • 4.2.1. Incorrect placement of these devices
    • 4.2.2. High cost of these devices
  • 4.3. Vascular Access Devices Market Opportunities
    • 4.3.1. Growing preference for adequate delivery of fluids in kidney disease patients
    • 4.3.2. Growing availability of devices coated with bioactive materials

5. Vascular Access Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Vascular Access Devices Market layout

  • 6.1. By Device Type
    • 6.1.1. Central Vascular Access Devices
      • 6.1.1.1. Peripherally Inserted Central Catheters (PICC)
      • 6.1.1.2. Non-Tunneled Catheters
      • 6.1.1.3. Others
    • 6.2.1. Peripheral Vascular Access Devices
      • 6.2.1.1. Peripheral Catheter
      • 6.2.1.2. Midline Catheter (Short) Devices
      • 6.2.1.3. Others
  • 6.2. By Route of Insertion
    • 6.2.1. Intravenous
    • 6.2.2. Subcutaneous
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centres
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.1.1. United States Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.1.2. Canada Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.1.3. Mexico Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.2. Europe Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.1. France Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.2. Germany Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.4. Italy Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.5. Spain Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.1. China Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.2. Japan Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.3. India Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.4. Australia Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.5. South Korea Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.4.1. Middle East Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.4.2. Africa Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.4.3. South America Vascular Access Devices Market in USD million (2021-2030)

7. Vascular Access Devices Company and Product Profiles

  • 7.1. Cook Medical Inc.
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Becton, Dickinson, and Company
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Teleflex Incorporated
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Medtronic PLC
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. B Braun Melsungen AG
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Nipro Medical Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Smiths Group PLC
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. C. R. Bard, Inc.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Edwards Lifesciences Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. AngioDynamics
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Terumo Medical Corporation
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Amecath Medical Technologies
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Prodimed
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. B Braun Melsungen AG
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Zoll Medical Corporation
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Vascular Access Devices Market in Global (2021-2030)
  • Table 3: Vascular Access Devices Market in Global by Device Type (2021-2030)
  • Table 4: Vascular Access Devices Market in Global by Route of Insertion (2021-2030)
  • Table 5: Vascular Access Devices Market in Global by End-User (2021-2030)
  • Table 6: Vascular Access Devices Market in Global by Geography (2021-2030)
  • Table 7: Vascular Access Devices Market in North America (2021-2030)
  • Table 8: Vascular Access Devices Market in the US (2021-2030)
  • Table 9: Vascular Access Devices Market in Canada (2021-2030)
  • Table 10: Vascular Access Devices Market in Mexico (2021-2030)
  • Table 11: Vascular Access Devices Market in Europe (2021-2030)
  • Table 12: Vascular Access Devices Market in France (2021-2030)
  • Table 13: Vascular Access Devices Market in Germany (2021-2030)
  • Table 14: Vascular Access Devices Market in the United Kingdom (2021-2030)
  • Table 15: Vascular Access Devices Market in Italy (2021-2030)
  • Table 16: Vascular Access Devices Market in Spain (2021-2030)
  • Table 17: Vascular Access Devices Market in Rest of Europe (2021-2030)
  • Table 18: Vascular Access Devices Market in Asia Pacific (2021-2030)
  • Table 19: Vascular Access Devices Market in China (2021-2030)
  • Table 20: Vascular Access Devices Market in Japan (2021-2030)
  • Table 21: Vascular Access Devices Market in India (2021-2030)
  • Table 22: Vascular Access Devices Market in Australia (2021-2030)
  • Table 23: Vascular Access Devices Market in South Korea (2021-2030)
  • Table 24: Vascular Access Devices Market in Rest of Asia Pacific (2021-2030)
  • Table 25: Vascular Access Devices Market in the Rest of the World (2021-2030)
  • Table 26: Vascular Access Devices Market in the Middle East (2021-2030)
  • Table 27: Vascular Access Devices Market in Africa (2021-2030)
  • Table 28: Vascular Access Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Vascular Access Devices Market in Global (2021-2030)
  • Figure 3: Vascular Access Devices Market in Global by Device Type (2021-2030)
  • Figure 4: Vascular Access Devices Market in Global by Route of Insertion (2021-2030)
  • Figure 5: Vascular Access Devices Market in Global by End-User (2021-2030)
  • Figure 6: Vascular Access Devices Market in Global by Geography (2021-2030)
  • Figure 7: Vascular Access Devices Market in North America (2021-2030)
  • Figure 8: Vascular Access Devices Market in the US (2021-2030)
  • Figure 9: Vascular Access Devices Market in Canada (2021-2030)
  • Figure 10: Vascular Access Devices Market in Mexico (2021-2030)
  • Figure 11: Vascular Access Devices Market in Europe (2021-2030)
  • Figure 12: Vascular Access Devices Market in France (2021-2030)
  • Figure 13: Vascular Access Devices Market in Germany (2021-2030)
  • Figure 14: Vascular Access Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Vascular Access Devices Market in Italy (2021-2030)
  • Figure 16: Vascular Access Devices Market in Spain (2021-2030)
  • Figure 17: Vascular Access Devices Market in the Rest of Europe (2021-2030)
  • Figure 18: Vascular Access Devices Market in Asia Pacific (2021-2030)
  • Figure 19: Vascular Access Devices Market in China (2021-2030)
  • Figure 20: Vascular Access Devices Market in Japan (2021-2030)
  • Figure 21: Vascular Access Devices Market in India (2021-2030)
  • Figure 22: Vascular Access Devices Market in Australia (2021-2030)
  • Figure 23: Vascular Access Devices Market in South Korea (2021-2030)
  • Figure 24: Vascular Access Devices Market in the Rest of Asia Pacific (2021-2030)
  • Figure 25: Vascular Access Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Vascular Access Devices Market in the Middle East (2021-2030)
  • Figure 27: Vascular Access Devices Market in Africa (2021-2030)
  • Figure 28: Vascular Access Devices in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER'S Five Force Analysis